![Suzanne Blaug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Suzanne Blaug
Plus aucun poste en cours
Profil
Suzanne Blaug's former jobs include being the Managing Director at Johnson & Johnson, an Independent Director at FibroGen, Inc. from 2019 to 2024, the SVP-Global Marketing & Commercial Development at Amgen, Inc. from 2012 to 2018, the Head of Janssen Alzheimer Immunotherapy from 2009 to 2012, and a Principal at EMEA Capital LLP.
She also served as the Vice President-Europe Strategic Marketing at Janssen Global Services LLC from 2005 to 2009.
Ms. Blaug obtained an undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Kellogg School of Management.
Anciens postes connus de Suzanne Blaug
| Sociétés | Poste | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Directeur/Membre du Conseil | 30/09/2024 |
| AMGEN INC. | Sales & Marketing | 01/08/2018 |
Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | 01/03/2012 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Corporate Officer/Principal | 01/10/2009 |
EMEA Capital LLP
 EMEA Capital LLP Investment ManagersFinance EMEA Capital mainly invests across financial markets, financial technology and private equity. | Corporate Officer/Principal | - |
Formation de Suzanne Blaug
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Alzheimer Immunotherapy | |
EMEA Capital LLP
EMEA Capital LLP Investment ManagersFinance EMEA Capital mainly invests across financial markets, financial technology and private equity. | Finance |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
